These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 18790549)

  • 81. Pathway-specific alteration of synaptic plasticity in Tg2576 mice.
    Jung JH; An K; Kwon OB; Kim HS; Kim JH
    Mol Cells; 2011 Aug; 32(2):197-201. PubMed ID: 21638202
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.
    Tan VTY; Mockett BG; Ohline SM; Parfitt KD; Wicky HE; Peppercorn K; Schoderboeck L; Yahaya MFB; Tate WP; Hughes SM; Abraham WC
    Mol Brain; 2018 Feb; 11(1):7. PubMed ID: 29426354
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Intracerebroventricular transplantation of human amniotic epithelial cells ameliorates spatial memory deficit in the doubly transgenic mice coexpressing APPswe and PS1ΔE9-deleted genes.
    Xue SR; Chen CF; Dong WL; Hui GZ; Liu TJ; Guo LH
    Chin Med J (Engl); 2011 Sep; 124(17):2642-8. PubMed ID: 22040417
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
    Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
    Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice.
    Kemppainen S; Rantamäki T; Jerónimo-Santos A; Lavasseur G; Autio H; Karpova N; Kärkkäinen E; Stavén S; Vicente Miranda H; Outeiro TF; Diógenes MJ; Laroche S; Davis S; Sebastião AM; Castrén E; Tanila H
    Neurobiol Aging; 2012 Jun; 33(6):1122.e23-39. PubMed ID: 22209410
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice.
    Kuwabara Y; Ishizeki M; Watamura N; Toba J; Yoshii A; Inoue T; Ohshima T
    J Neurochem; 2014 Aug; 130(3):432-43. PubMed ID: 24684630
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.
    Cheng D; Low JK; Logge W; Garner B; Karl T
    Behav Brain Res; 2014 Mar; 260():111-8. PubMed ID: 24315833
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Neuregulin-1 prevents amyloid β-induced impairment of long-term potentiation in hippocampal slices via ErbB4.
    Min SS; An J; Lee JH; Seol GH; Im JH; Kim HS; Baik TK; Woo RS
    Neurosci Lett; 2011 Nov; 505(1):6-9. PubMed ID: 21787838
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hippocampal synaptic activity, pattern separation and episodic-like memory: implications for mouse models of Alzheimer's disease pathology.
    Palmer A; Good M
    Biochem Soc Trans; 2011 Aug; 39(4):902-9. PubMed ID: 21787321
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reduced basal and novelty-induced levels of activity-regulated cytoskeleton associated protein (Arc) and c-Fos mRNA in the cerebral cortex and hippocampus of APPswe/PS1ΔE9 transgenic mice.
    Christensen DZ; Thomsen MS; Mikkelsen JD
    Neurochem Int; 2013 Jul; 63(1):54-60. PubMed ID: 23598246
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice.
    Brown JT; Richardson JC; Collingridge GL; Randall AD; Davies CH
    Hippocampus; 2005; 15(1):110-7. PubMed ID: 15390159
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Behavioral and neuropathological consequences of transient global ischemia in APP/PS1 Alzheimer model mice.
    Kemppainen S; Hämäläinen E; Miettinen PO; Koistinaho J; Tanila H
    Behav Brain Res; 2014 Dec; 275():15-26. PubMed ID: 25192639
    [TBL] [Abstract][Full Text] [Related]  

  • 95. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
    Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
    Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
    Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    Choi Y; Jeong HJ; Liu QF; Oh ST; Koo BS; Kim Y; Chung IW; Kim YS; Jeon S
    Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's disease.
    Hascup KN; Hascup ER
    J Alzheimers Dis; 2015; 44(3):771-6. PubMed ID: 25374106
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Physiol Behav; 2011 Oct; 104(5):880-5. PubMed ID: 21640739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.